RVL Pharmaceuticals plc 3/A SEC Filings

Filed On	Filing
19 Oct 2018	Form 3/A: Einhorn Andrew J., Chief Financial Officer Holds 22,852 shares of Ordinary Shares
19 Oct 2018	Form 3/A: Venkataraman Sriram, Director Holds 9,296,965 shares of Ordinary Shares
19 Oct 2018	Form 3/A: Burgstahler David F, Director Holds 9,296,965 shares of Ordinary Shares
19 Oct 2018	Form 3/A: Avista Capital Partners Iii GP, L.p., 10% owner and 4 others Holds 9,296,965 shares of Ordinary Shares

Comments